Doctor Cosme Garcia-Garcia

Doctor Cosme Garcia-Garcia

Germans Trias i Pujol University Hospital, Barcelona (Spain)

Dr. Cosme Garcia, MD, PhD, Head of the Cardiology Department at the Heart Institute ol Germans Trias i Pujol University Hospital (2025), before that, Chief of Acute Cardiac Care Unit (2015). Associate Professor at the Autonomous University of Barcelona (2021--). Degree in Medicine and Surgery in 1998 at the University of Barcelona, specialization in Cardiology and Doctorate in Medicine, graduating cum laude in 2013. He holds European certification from the ACCA. He enriched his expertise with Diploma in Health Sciences Statistics (2006), and Master’s Degrees in Acute Cardiac Care (2014) and Master in Direction and Management of Clinical Units (2017). He has directed 8 doctoral theses, authored more than 80 peer-reviewed publications, more than 250 scientific communications, and leadership in multiple competitive research projects, including grants from the Carlos III Health Institute. Cardiogenic shock, myocardial infartion and cardiovascular epidemiology are his research areas.

Presentations Articles

Primary ventricular fibrillation in the STEMI code era: trends and acute-phase mortality over the last 15 years

Event: ESC Congress 2025

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Cardiogenic shock in acute coronary syndromes

Access

Prognostic implications of fasting hyperglycaemia in patients with cardiogenic shock. A mediterranean cohort: results from the Shock-CAT study.

Event: ESC Congress 2025

Topic: Cardiogenic Shock

Session: The kidney and other comorbidities in cardiogenic shock

Access

Primary ventricular fibrillation epidemic in the STEMI Code era. Trends and acute-phase mortality over the last 15 years

Event: ESC Acute CardioVascular Care 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Arrhythmias in acute cardiac care

Access

Concomitant cardiac arrest on cardiogenic shock patients. Differences in clinical profile and outcomes with non-cardiac arrest patients. The Shock CAT Study

Event: ESC Congress 2024

Topic: Shock

Session: Arrhythmias and acute coronary syndromes: focus on atrial fibrillation and cardiac arrest

Access

Gender-based differences in clinical profile, management and mortality in cardiogenic shock. Prognostic accuracy of CardShock vs IABP Score, the Shock-CAT study

Event: ESC Acute CardioVascular Care 2024

Topic: Cardiogenic Shock

Session: Cardiogenic shock: epidemiology and prognostication

Access

In-hospital mortality and 6-months prognosis on cardiogenic shock depending on the aetiology in a Mediterranean cohort. The Shock-CAT Study

Event: ESC Acute CardioVascular Care 2022

Topic: Cardiogenic Shock

Session: e-Posters session

Access

Mortality risk in cardiogenic shock: Head to head comparison CardShock vs IABP score depending on aetiology, the Shock CAT study

Event: ESC Acute CardioVascular Care 2022

Topic: Cardiogenic Shock

Session: e-Posters session

Access

Mortality risk in cardiogenic shock: head to head comparision CardShock vs IABP Score in a Mediterranean cohort, the Shock CAT Study

Event: ESC Congress 2021 - The Digital Experience

Topic: Shock

Session: Acute Coronary Syndromes ePosters

Access

Mortality risk in cardiogenic shock depending on aetiology in a Mediterranean cohort. Prognostic accuracy of CardShock vs IABP Score, the Shock CAT Study

Event: ESC Congress 2021 - The Digital Experience

Topic: Shock

Session: Acute Coronary Syndromes ePosters

Access

Cardiogenic shock in ST elevation myocardial infarction: prevalence, management and acute phase and one-year mortality over the last three decades

Event: ESC Congress 2019

Topic: Shock

Session: Cardiogenic shock

Access

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources

Doctor Cosme Garcia-Garcia

Biography

Contributor content

Primary ventricular fibrillation in the STEMI code era: trends and acute-phase mortality over the last 15 years

Prognostic implications of fasting hyperglycaemia in patients with cardiogenic shock. A mediterranean cohort: results from the Shock-CAT study.

Primary ventricular fibrillation epidemic in the STEMI Code era. Trends and acute-phase mortality over the last 15 years

Concomitant cardiac arrest on cardiogenic shock patients. Differences in clinical profile and outcomes with non-cardiac arrest patients. The Shock CAT Study

Gender-based differences in clinical profile, management and mortality in cardiogenic shock. Prognostic accuracy of CardShock vs IABP Score, the Shock-CAT study

In-hospital mortality and 6-months prognosis on cardiogenic shock depending on the aetiology in a Mediterranean cohort. The Shock-CAT Study

Mortality risk in cardiogenic shock: Head to head comparison CardShock vs IABP score depending on aetiology, the Shock CAT study

Mortality risk in cardiogenic shock: head to head comparision CardShock vs IABP Score in a Mediterranean cohort, the Shock CAT Study

Mortality risk in cardiogenic shock depending on aetiology in a Mediterranean cohort. Prognostic accuracy of CardShock vs IABP Score, the Shock CAT Study

Cardiogenic shock in ST elevation myocardial infarction: prevalence, management and acute phase and one-year mortality over the last three decades

ESC 365 is supported by

Doctor Cosme Garcia-Garcia Follow

Biography

Contributor content

Primary ventricular fibrillation in the STEMI code era: trends and acute-phase mortality over the last 15 years

Prognostic implications of fasting hyperglycaemia in patients with cardiogenic shock. A mediterranean cohort: results from the Shock-CAT study.

Primary ventricular fibrillation epidemic in the STEMI Code era. Trends and acute-phase mortality over the last 15 years

Concomitant cardiac arrest on cardiogenic shock patients. Differences in clinical profile and outcomes with non-cardiac arrest patients. The Shock CAT Study

Gender-based differences in clinical profile, management and mortality in cardiogenic shock. Prognostic accuracy of CardShock vs IABP Score, the Shock-CAT study

In-hospital mortality and 6-months prognosis on cardiogenic shock depending on the aetiology in a Mediterranean cohort. The Shock-CAT Study

Mortality risk in cardiogenic shock: Head to head comparison CardShock vs IABP score depending on aetiology, the Shock CAT study

Mortality risk in cardiogenic shock: head to head comparision CardShock vs IABP Score in a Mediterranean cohort, the Shock CAT Study

Mortality risk in cardiogenic shock depending on aetiology in a Mediterranean cohort. Prognostic accuracy of CardShock vs IABP Score, the Shock CAT Study

Cardiogenic shock in ST elevation myocardial infarction: prevalence, management and acute phase and one-year mortality over the last three decades

ESC 365 is supported by

Doctor Cosme Garcia-Garcia